My goal has always been to draw a clear line on defining what a traditional compounding pharmacy is, and that should be regulated by the States, and what a manufacturer, a drug manufacturer is, which properly should be regulated by the FDA.
Pitts emphasizes the need to distinguish between compounding pharmacies and drug manufacturers for regulation.
Share
More from Joe Pitts
I thank Mr. Murphy for his leadership and his persistence in getting this historic legislation to the floor. When a person struggles with mental illness, he or she may lose her job, her friends, even her family, which can make the mental…
H.R. 1807, the Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015, sponsored by Rep. Danny Davis (IL) and Rep. Michael Burgess (TX) reauthorizes a sickle cell disease demonstration program.
Explicitly creating a program exclusively for catfish seems to be unnecessary, and it directs resources away from high-risk foods.
Other voices in this conversation
